ABSTRACT
Chiropractic care is a commonly used treatment modality for musculoskeletal pain in pregnancy. Low back pain, pelvic pain, and other neuromuscular complaints are prevalent in pregnancy and contribute to significant maternal discomfort in many women. Nonpharmacologic therapies to relieve pain are increasingly important during pregnancy because of the opioid epidemic. Chiropractic treatment is one of the potential therapies that offers intervention without medications. This article provides an evidence-based review of the epidemiology of chiropractic use in obstetrics, commonly treated conditions, related physiology of pregnancy, and safety of spinal manipulation.
Subject(s)
Chiropractic , Low Back Pain , Manipulation, Chiropractic , Pregnancy Complications , Female , Humans , Low Back Pain/therapy , Pelvic Pain , Pregnancy , Pregnancy Complications/therapyABSTRACT
Importance: Obesity increases the risk of both cesarean delivery and surgical-site infection. Despite widespread use, it is unclear whether prophylactic negative pressure wound therapy reduces surgical-site infection after cesarean delivery in obese women. Objective: To evaluate whether prophylactic negative pressure wound therapy, initiated immediately after cesarean delivery, lowers the risk of surgical-site infections compared with standard wound dressing in obese women. Design, Setting, and Participants: Multicenter randomized trial conducted from February 8, 2017, through November 13, 2019, at 4 academic and 2 community hospitals across the United States. Obese women undergoing planned or unplanned cesarean delivery were eligible. The study was terminated after 1624 of 2850 participants were recruited when a planned interim analysis showed increased adverse events in the negative pressure group and futility for the primary outcome. Final follow-up was December 18, 2019. Interventions: Participants were randomly assigned to either undergo prophylactic negative pressure wound therapy, with application of the negative pressure device immediately after repair of the surgical incision (n = 816), or receive standard wound dressing (n = 808). Main Outcomes and Measures: The primary outcome was superficial or deep surgical-site infection according to the Centers for Disease Control and Prevention definitions. Secondary outcomes included other wound complications, composite of surgical-site infections and other wound complications, and adverse skin reactions. Results: Of the 1624 women randomized (mean age, 30.4 years, mean body mass index, 39.5), 1608 (99%) completed the study: 806 in the negative pressure group (median duration of negative pressure, 4 days) and 802 in the standard dressing group. Superficial or deep surgical-site infection was diagnosed in 29 participants (3.6%) in the negative pressure group and 27 (3.4%) in the standard dressing group (difference, 0.36%; 95% CI, -1.46% to 2.19%, P = .70). Of 30 prespecified secondary end points, 25 showed no significant differences, including other wound complications (2.6% vs 3.1%; difference, -0.53%; 95% CI, -1.93% to 0.88%; P = .46) and composite of surgical-site infections and other wound complications (6.5% vs 6.7%; difference, -0.27%; 95% CI, -2.71% to 2.25%; P = .83). Adverse skin reactions were significantly more frequent in the negative pressure group (7.0% vs 0.6%; difference, 6.95%; 95% CI, 1.86% to 12.03%; P < .001). Conclusions and Relevance: Among obese women undergoing cesarean delivery, prophylactic negative pressure wound therapy, compared with standard wound dressing, did not significantly reduce the risk of surgical-site infection. These findings do not support routine use of prophylactic negative pressure wound therapy in obese women after cesarean delivery. Trial Registration: ClinicalTrials.gov Identifier: NCT03009110.
Subject(s)
Bandages , Cesarean Section/adverse effects , Negative-Pressure Wound Therapy , Obesity , Surgical Wound Infection/prevention & control , Adult , Anti-Bacterial Agents/therapeutic use , Bandages/adverse effects , Blister/etiology , Body Mass Index , Cesarean Section/methods , Female , Humans , Negative-Pressure Wound Therapy/adverse effects , Pregnancy , Pregnancy ComplicationsABSTRACT
BACKGROUND: Cell-free DNA screen failures or "no calls" occur in 1-12% of samples and are frustrating for both clinician and patient. The rate of "no calls" has been shown to have an inverse relationship with gestational age. Recent studies have shown an increased risk for "no calls" among obese women. OBJECTIVE: We sought to determine the optimal gestational age for cell-free DNA among obese women. STUDY DESIGN: We performed a retrospective cohort study of women who underwent cell-free DNA at a single tertiary care center from 2011 through 2016. Adjusted odds ratios with 95% confidence intervals for a "no call" were determined for each weight class and compared to normal-weight women. The predicted probability of a "no call" with 95% confidence intervals were determined for each week of gestation for normal-weight and obese women and compared. RESULTS: Among 2385 patients meeting inclusion criteria, 105 (4.4%) had a "no call". Compared to normal-weight women, the adjusted odds ratio of a "no call" increased with increasing weight class from overweight to obesity class III (respectively: adjusted odds ratio, 2.31; 95% confidence interval, 1.21-4.42 to adjusted odds ratio, 8.55; 95% confidence interval, 4.16-17.56). A cut point at 21 weeks was identified for obesity class II/III women at which there is no longer a significant difference in the probability of a "no call" for obese women compared to normal weight women. From 8-16 weeks, there is a 4.5% reduction in the probability of a "no call" for obesity class II/III women (respectively: 14.9%; 95% confidence interval, 8.95-20.78 and 10.4%; 95% confidence interval, 7.20-13.61; Ptrend < .01). CONCLUSION: The cut point of 21 weeks for optimal sampling of cell-free DNA limits reproductive choices. However, a progressive fall in the probability of a "no call" with advancing gestational age suggests that delaying cell-free DNA for obese women is a reasonable strategy to reduce the probability of a "no call".
Subject(s)
DNA/analysis , Genetic Testing , Gestational Age , Maternal Serum Screening Tests , Obesity/epidemiology , Overweight/epidemiology , Adult , Aneuploidy , Cohort Studies , Female , Humans , Missouri/epidemiology , Pregnancy , Retrospective StudiesABSTRACT
OBJECTIVE: Obstructive sleep apnea (OSA) is a risk factor for adverse perinatal outcomes. We aimed to test the hypothesis that maternal Mallampati class (MC), as a marker for OSA, is associated with adverse perinatal outcomes. STUDY DESIGN: We performed a retrospective secondary analysis of a prospective cohort of term births (≥ 37 weeks). Fetal anomalies and aneuploidy were excluded. Primary outcome was small for gestational age (SGA). Secondary outcomes included preeclampsia, neonatal cord arterial blood gas pH < 7.10 and < 7.05, base excess < - 8 and < - 12 mEq/L. Outcomes were compared between mothers with low MC airways and high MC airways using logistic regression. RESULTS: A total of 1,823 women met the inclusion criteria. No significant differences were found in the risk of SGA (adjusted odds ratio [aOR] 0.9, 95% confidence interval [CI] 0.6-1.2), preeclampsia (aOR 1.2, 95% CI 0.8-1.9) or neonatal acidemia (aOR 0.8, 95% CI 0.3-2.0), between high and low MC. CONCLUSION: High MC is not associated with adverse perinatal outcomes.
Subject(s)
Infant, Small for Gestational Age , Pregnancy Complications/epidemiology , Pregnancy Outcome , Sleep Apnea, Obstructive/classification , Sleep Apnea, Obstructive/epidemiology , Adult , Blood Gas Analysis , Body Mass Index , Female , Gestational Age , Humans , Infant, Newborn , Logistic Models , Multivariate Analysis , Odds Ratio , Polysomnography , Pre-Eclampsia/epidemiology , Pregnancy , Prognosis , Prospective Studies , Retrospective Studies , Risk Factors , Young AdultABSTRACT
In the roundtable that follows, clinicians discuss a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research.
Subject(s)
Pregnancy Complications/etiology , Sleep Apnea Syndromes/complications , Female , Humans , PregnancyABSTRACT
OBJECTIVE: Timing of delivery for the early preterm small-for-gestational-age (SGA) fetus remains unknown. Our aim was to estimate the risk of stillbirth in the early preterm SGA fetus compared with the risk of neonatal death. STUDY DESIGN: We performed a retrospective cohort study of singleton pregnancies that underwent second-trimester anatomy ultrasound (excluding fetal anomalies, aneuploidy, and pregnancies with incomplete neonatal follow-up data). SGA was defined as birthweight <10th percentile by the Alexander standard. Life-table analysis was used to calculate the cumulative risks of stillbirth per 10,000 ongoing SGA pregnancies and of neonatal death per 10,000 SGA live births for 2-week gestational age strata in the early preterm period (24-33 weeks 6 days of gestation). We further examined the composite risk of expectant management and then compared the risk of expectant management with the risk of immediate delivery. RESULTS: Of 76,453 singleton pregnancies, 7036 SGA pregnancies that met inclusion criteria were ongoing at 24 weeks of gestation; there were 64 stillbirths, 226 live births, and 18 neonatal deaths from 24-33 weeks 6 days of gestation. As the risk of stillbirth increases with advancing gestational age, the risk of neonatal death falls, until the 32-33 weeks 6 days of gestation stratum. The relative risk of expectant management compared with immediate delivery remains <1 for each gestational age strata. CONCLUSION: Our findings suggest that the balance between the competing risks of stillbirth and neonatal death for the early preterm SGA fetus occurs at 32-33 weeks 6 days of gestation. These data can be useful when delivery timing remains uncertain.
Subject(s)
Infant Mortality , Infant, Small for Gestational Age , Stillbirth , Cohort Studies , Humans , Infant, Newborn , Infant, Premature , Retrospective Studies , RiskABSTRACT
In the roundtable that follows, clinicians discuss a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research. Article discussed: Salmeen K, Brincat C. Time from consent to cesarean delivery during labor. Am J Obstet Gynecol 2013;209:212.e1-6.
Subject(s)
Cesarean Section , Informed Consent , Female , Humans , PregnancyABSTRACT
OBJECTIVE: The evidence for delivering small-for-gestational-age (SGA) fetuses at 37 weeks remains conflicting. We examined the risk of stillbirth per week of gestation beyond 37 weeks for pregnancies complicated by SGA. STUDY DESIGN: Singleton pregnancies undergoing routine second trimester ultrasound from 1990-2009 were examined retrospectively. The risk of stillbirth per 10,000 ongoing SGA pregnancies with 95% confidence intervals (CIs) was calculated for each week of gestation ≥37 weeks. Using a life-table analysis with correction for censoring, conditional risks of stillbirth, cumulative risks of stillbirth per 10,000 ongoing SGA pregnancies and relative risks (RRs) were calculated with 95% CIs for each week of gestation. RESULTS: Among 57,195 pregnancies meeting inclusion criteria the background risk of stillbirth was 56/10,000 (95% CI, 42.3-72.7) with stillbirth risk for SGA pregnancies of 251/10,000 (95% CI, 221.2-284.5). The risk of stillbirth after the 37th week was greater compared with pregnancies delivered in the 37th week (47/10,000, 95% CI, 34.6-62.5 vs 21/10,000, 95% CI, 13.0-32.1; RR, 2.2; 95% CI, 1.3-3.7). The cumulative risk of stillbirth rose from 28/10,000 ongoing SGA pregnancies at 37 weeks to 77/10,000 at 39 weeks (RR, 2.75; 95% CI, 1.79-4.2). Among pregnancies complicated by SGA <5% the cumulative risk of stillbirth at 38 weeks was significantly greater than the risk at 37 weeks (RR, 2.3; 95% CI, 1.4-3.8). CONCLUSION: There is a significantly increased risk of stillbirth in pregnancies complicated by SGA delivered after the 37th week. Given these findings, we advocate a policy of delivery of SGA pregnancies 37-38 weeks.
Subject(s)
Fetal Growth Retardation , Pregnancy Trimester, Third , Stillbirth , Adult , Female , Fetal Growth Retardation/diagnostic imaging , Follow-Up Studies , Gestational Age , Humans , Incidence , Infant, Newborn , Infant, Small for Gestational Age , Life Tables , Missouri/epidemiology , Pregnancy , Retrospective Studies , Risk , Stillbirth/epidemiology , UltrasonographyABSTRACT
OBJECTIVE: To generate a clinical prediction tool for stillbirth that combines maternal risk factors to provide an evidence based approach for the identification of women who will benefit most from antenatal testing for stillbirth prevention. DESIGN: Retrospective cohort study. SETTING: Midwestern United States quaternary referral center. POPULATION: Singleton pregnancies undergoing second trimester anatomic survey from 1999-2009. Pregnancies with incomplete follow-up were excluded. METHODS: Candidate predictors were identified from the literature and univariate analysis. Backward stepwise logistic regression with statistical comparison of model discrimination, calibration and clinical performance was used to generate final models for the prediction of stillbirth. Internal validation was performed using bootstrapping with 1,000 repetitions. A stillbirth risk calculator and stillbirth risk score were developed for the prediction of stillbirth at or beyond 32 weeks excluding fetal anomalies and aneuploidy. Statistical and clinical cut-points were identified and the tools compared using the Integrated Discrimination Improvement. MAIN OUTCOME MEASURES: Antepartum stillbirth. RESULTS: 64,173 women met inclusion criteria. The final stillbirth risk calculator and score included maternal age, black race, nulliparity, body mass index, smoking, chronic hypertension and pre-gestational diabetes. The stillbirth calculator and simple risk score demonstrated modest discrimination but clinically significant performance with no difference in overall performance between the tools [(AUC 0.66 95% CI 0.60-0.72) and (AUC 0.64 95% CI 0.58-0.70), (p = 0.25)]. CONCLUSION: A stillbirth risk score was developed incorporating maternal risk factors easily ascertained during prenatal care to determine an individual woman's risk for stillbirth and provide an evidenced based approach to the initiation of antenatal testing for the prediction and prevention of stillbirth.
Subject(s)
Models, Statistical , Stillbirth , Adult , Aneuploidy , Comorbidity , Databases, Factual , Female , Humans , Odds Ratio , Pregnancy , Prognosis , Reproducibility of Results , Risk Assessment , Risk Factors , Sensitivity and SpecificityABSTRACT
Open spina bifida is a non-lethal fetal anomaly. Significant advances in the prevention, diagnosis and treatment of open spina bifida have been made over the past 75 years. The most significant strategy for the prevention of open spina bifida has been with folic acid supplementation; however, further investigation into the complicated role that genetics and the environment play in metabolism are coming to light. Ultrasound is the gold standard diagnostic tool for spina bifida. Three-dimensional ultrasound and magnetic resonance imaging are also beginning to play a role in the characterisation of the open spina bifida spinal lesion. Lesion level has been closely correlated to short and long-term outcomes, and prenatal characterisation of lesion level on ultrasound is important for patient counselling. Long-term outcomes of people living with spina bifida are available and should be used for non-directive patient counselling about pregnancy choices for women with open spina bifida.